1. Final results of a randomized controlled phase III trial (TAX 325) comparing docetaxel (T) combined with cisplatin (C) and 5-fluorouracil (F) in patients (pts) with metastatic gastric adenocarcinoma;Moiseyenko;J Clin Oncol,2005
2. Moiseyenko V, Van Cutsem E, Tjulandin S, et al. Adding docetaxel to cisplatin-5-fluorouracil improves quality of life in advanced gastric cancer: a Phase III trial. 7th World Congress on Gastro-intestinal Cancer, Barcelona, Spain, 15–18 June 2005 (Abstract O–013).
3. Van Cutsem E, Moiseyenko V, Tjulandin S, et al. Docetaxel when added to cisplatin-5-fluorouracil improves survival in advanced gastric cancer: a Phase III trial. 7th World Congress on Gastro-intestinal Cancer, Barcelona, Spain, 15–18 June 2005 (Abstract O–012).
4. Randomized phase II study evaluating weekly docetaxel in combination with cisplatin and 5FU or capecitabine in metastatic oesophago-gastric cancer;Tebbutt;J Clin Oncol,2006
5. Randomized multicenter phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric (OG) cancer: the REAL 2 trial;Cunningham;J Clin Oncol,2006